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Summary
The Fas gene encodes a cell surface molecule that is a member of the the nerve growth factor/tumor
necrosis factor receptor family of proteins and can mediate programmed cell death (apoptosis)
in certain transformed cell lines. To characterize further the biological function ofFas, particularly
with regard to its function in normal cells, a panel of monoclonal antibodies (mAbs) was generated
against the extracellular portion of humanFas. Some of these mAbs induced apoptosis in transformed
cell lines expressing Fas, but only when immobilized on the culture vessel. One of the new
Fas mAbs (M38) was used for studies on normal lymphoid cells and found to stimulate the
proliferation ofpurified human T cells and thymocytes when immobilized on culture wells along
with CD3 antibody. T cell proliferation induced by Fas mAb was largely interleukin 2 independent
and was demonstrated to be due to a direct effect on the precursor T cell. Thus, the data demonstrate
that in addition to a role in the induction of apoptosis in certain transformed cell lines, the Fas
protein may also play an important role in the activation and proliferation of normal T cells.
F
as (also termed APO-1) was first described as a molecule
expressed on the surface of certain cell lines that could
mediate programmed cell death, termed apoptosis, when
ligated by a specific mAb (1, 2). Little is known, however,
about the function of Fas on normal cells. Molecular cloning
of the gene encoding human Fas (huFas) revealed it to be
a member of a family of related proteins that include the
receptors for nerve growth factor and tumor necrosis factor,
the CD27, CD30, CD40, 41BB, and OX40 antigens, and
the pox virus gene product T2 which encodes a soluble pro-
tein capable ofbinding TNF (3-13). Ofconsiderable interest
was the recent demonstration that the autoimmune disease
that develops in mice homozygous at the lpr gene locus is
due to a defect in Fas gene expression (14). Thus, a more
complete understanding of the biology of Fas may provide
insight into its role in normal immune responses as well as
in the generation of autoimmune disease.
For this studywe generated a panel ofmAbs against huFas
and examined the effects of these Fas-specific antibodies on
freshly isolated human T lymphocytes that couldbe induced
to express Fas. Our data indicate the existence of a complex
set of interactions mediated by Fas that may have important
implications regarding the role(s) of this molecule in normal
immune responses in addition to its apparent association with
autoimmune disease.
Materials and Methods
Generation ofFas mAh
￿
BALB/cj mice (The Jackson Labora-
tory, Bar Harbor, ME) were immunized with a purified fusion pro-
tein consisting of the extracellular domain of human Fas coupled
to the constant region of human IgGl (huFas.Fc) in Freund's adju-
vant. Mice were boosted six times and spleen cells were fused with
the murine myeloma 8 .653 in the presence of 50% polyethylene
glycol/10% DMSO in PBS followed by culture in DMEM/HAT
and DMEM/HT selective media. Supernatants from positive wells
were tested for the ability to bind biotinylated huFas.Fcin an ELISA
and by reactivity to huFas.Fc in Western and dot blots. Hybrid-
omas that produced Abs positive for binding to huFas.Fc but not
to human IgG1 were cloned by limitdilution threetimes. All mAbs
were determined to be of the IgGl isotype and were purified by
protein A affinity chromatography.
Reagents.
￿
The IgM huFas mAb, clone CH-11, was purchased
from Medical and Biological Laboratories (Nagoya, Japan). Immobi-
lized CD3 mAb OKT3 was used to costimulate peripheral blood
T cells and thymocytes at 1 ug/ml. PE-conjugated CD4 and CD8
and FITC-conjugated CD25 and CD69 together with PE- and
FITC-conjugated isotype matched control antibodieswere purchased
from Becton Dickinson & Co. (Mountain View, CA). A neu-
tralizing rabbit antiserum generated against human IL2 was used
at a 1:500 dilution, a concentration that could totally inhibit up
to 10 ng/ml of IL2.
T Cell Costimulation Assay.
￿
T cells were enriched from PBMC
by rosetting with 2-aminoethyl isothiouronium bromide hydrobro-
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ence for 1 h at 37°C and the resulting population of cells was >95%
CD3` by flow rytometry. Thymocytes were obtained from infants
undergoing corrective cardiac surgery and isolated by Ficoll den-
sity centrifugation . Peripheral blood (PB) T cells and thymocytes
were cultured at 1 x 105 per well in 96-well flat-bottomed plates
that had been previously coated withmAb as described above. Cul-
tures were incubated at 37°C in a humidified atmosphere of 5%
COZ in air for 3 d and pulsed with 1 '.Ci of 13H]TdR for the final
6 h ofculture. Wells were then harvested and incorporated radio-
activity was determined using a Matrix 96 beta counter (Packard
Instrument Company, Inc ., Meriden, CT) .
CytokineAssays .
￿
Cultures for the measurement ofIL2 produc-
tion were performed in the presence of an IL2R p55 mAb (2A3)
to prevent utilization of 11,2 produced by the T cells . IL2 levels
were measured in a CTLL bioassay (15) using recombinant human
IL2 as a standard. IFN- ,y and TNF-tx levels were determined by
ELISA, as described previously (16) .
Limit Dilution Analysis.
￿
Analysis of the frequency ofproliferating
human T cell precursors was assessed in microcultures, as described
previously using murine T cells (17, 18) . T cells were cultured in
60-well Terasaki trays that had been precoated with OKT3 (10
,ug/ml) either with or without huFas M38mAb (10 /cg/ml) over-
night at 4°C. Cells were cultured in the presence of11,2 (10 ng/ml)
in a total volume of 15 ul at 1-20 cells/well . After 5 d of culture,
wells were visually examined for the presence or absence ofprolifer-
ating T cells using an inverted phase-contrast microscope. A well
was scored positive if one or more clusters of at least three blast
cells were observed or ifthe number ofblasts present was greater
than the input number. Estimates ofthe frequency ofproliferating
cell precursors weredeterminedfrom the Poisson distribution rela-
tionship between the number ofinput cells and the percent nega-
tive wells using the minimum 7(2 method (19) . Clone size esti-
mates were made by counting the number of cells per well and
then adjusting for clonal overlap based upon the Poisson distribution .
Flow Cytometry .
￿
Cells to be analyzed for expression ofT cell
activation molecules were first incubated at 4°C in a blocking so-
lution ofPBS containing2% normal rabbit serum and2% normal
goat serum to prevent nonspecific binding ofmouse Ig . Cells were
washed in FACS® buffer (PBS/1% FCS/0.02% sodium azide) and
incubated with CD4-PE or CD8-PE in conjunction with CD25-
FITC or CD69-FITC mAb for 30 min at 4°C. Quadrants were
set by analysis of cells incubated with PE- and FITC-conjugated
isotype matched control antibodies . Flow cytometry was performed
using a FACScan® (Becton Dickinson and Co.) and data were col-
lected on 104 viable cells .
Results and Discussion
Fas mAbs Costimulate T Lymphocyte Activation .
￿
The two
mAbs that initially defined the Fas antigen, namely clone
CH-11 and the anti-APO-1 mAbs, were identified based upon
their ability to induce death of certain cell lines in vitro (1,
2) . Thus, it was of interest to determine whether this was
a general characteristic of all Fas-specific Abs or whether Abs
selected solely by their ability to bind Pas would have different
biological properties. A soluble Pas fusion protein consisting
of the extracellular portion of huFas coupled to the Fc do-
main ofhuman IgG1(huFas.Fc) was used to immunize mice
and generate a panel ofmAbs that were reactive with huFas.Fc
but not human IgG1 by ELISA (data not shown) . Several
of these mAbs induced apoptosis in transformed cell lines
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expressing Pas (such asJurkat or U937), but only if themAbs
were immobilized on the culture vessel (data not shown) .
The ability of our huFas-specific mAb to bind to freshly
isolated normalhuman leukocytes or leukocytes cultured with
mitogenic stimuli was assessed by flow rytometry. Although
specific binding to neutrophils, monocytes, Staphylococcus aumus
cowen-activated B cells, and PHA-induced T cell blasts was
detected, none of these cell types were induced to undergo
cytolysis when cultured with either soluble or immobilized
huFasmAb (data not shown) . These results support recently
published data demonstrating strong expression of Pas byPHA
blasts, but no adverse effect on cell viability upon exposure
to huFasmAb (20) . Given that mAbs against another member
of the nerve growth factor receptor (NGFR)/tumor necrosis
factor receptor (TNFR) family (namely CD27) have been
shown to costimulate T cell proliferation (21), we questioned
whether immobilized huFasmAb would costimulate T cells
in conjunction with solid-phase CD3 mAb . Some, but not
all, of the huFas mAbs were found to be strong costimu-
lators ofT cell proliferation with activity equivalent to, or
greater than, that ofIL-2 . For example, huFasM38 costimu-
lated T cell proliferation at concentrations as low as 100 ng/ml
(Fig. 1 A) . Those huFas mAbs that did costimulate T cell
proliferation, including CH-11, had this activity only when
immobilized and not when added to cultures in solution
(Fig. 1 B) .
Given that activated thymocytes express Fas, we assessed
whether these cells could also be activated by huFas Ab. Al-
though results ofa recent study suggested that Fas can mediate
lysis of normal murine thymocytes in a 4-h "Cr-release assay
(22), we found that human thymocytes were costimulated
to proliferate by immobilized huFas mAbs in the presence
of CD3 mAb (Fig . 1 C) . Thus, it is possible that subsets
ofthymocytesmay respond differentially to signals mediated
by Fas. Alternatively, it is also possible that qualitatively
different responses (apoptosis or activation) may be induced
in thymocytes stimulated through Fas alonewhen compared
with costimulation in the presence of CD3 antibody.
Ligation ofFas Costimulates Enhanced Expression ofT Cell
Activation Molecules. To analyze the effect of Pas mAb on
human T cells in more detailwe used flow cytometry to de-
termine whether the costimulation of T cells by huFas Ab
was accompanied by enhanced expression ofT cell activation
molecules. Two such molecules, the early activation antigen
CD69 and the p55 low affinity chain of the IL-2 receptor
CD25, were strongly enhanced on T cells stimulated with
huFas M38 plus CD3 mAb compared with CD3 mAb alone
(Fig. 2) . Enhanced expression of CD25 and CD69 was de-
tected on both CD4+ and CD8+ T cells . Ligation of Pas
by immobilized huFas M38 in the presence of CD3 mAb
also induced modest increases in expression of the adhesion
molecules CD11a (LFA-1), CD18, and CD54 (ICAM-1) (data
not shown) .
Role of Cytokines in Fas-mediated Costimulation of T
Cells. Two approaches were used to determine whether the
activation ofhuman T cells by Pas mAb was dependent upon
soluble cytokine production . First, we assessed whether T
cells costimulated with Fas mAb increased their cytokine40000
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Figure 1 .
￿
Costimulation ofT lymphocyte proliferation by huFasmAb .
(A) PB T cells were cultured with titrated concentrations of immobilized
Fas M38 mAb either with (*)or without (O) immobilized CD3 mAb
(1 ug/ml) for 3 d and pulsed with [ 3H]TdR for the final 6 h. (B) PB T
cells were cultured with immobilizedCD3 mAb and titrated concentra-
tions ofeither soluble(O) or immobilized (") CH-11 FasmAb. (C) Thymo-
cytes were cultured with titrated concentrations ofimmobilizedhuFasmAb
in the presence (") or absence (O) of immobilizedCD3 mAb. Data rep-
resent mean ± SD of triplicate cultures and are representative of six (A),
three (B), and four (C) experiments performed .
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Purified T cells were cultured for 48 h with various stimuli and superna-
tants harvested. Cultures for measuring IL-2 production were performed
in the presence of an IL-2R p55 mAb to prevent utilization of IL-2 by
the T cells and IL-2 levels were measured by a CTLL bioassay . IFN-y
and TNF-a levels were measured by ELISA . Data are representative of
three experiments .
production. T cells stimulated with huFas M38 plus CD3
mAb were found to produce N10-fold more IL-2, IFN-'y ,
and TNF-a than cells stimulated with CD3mAb alone (Table
1) . Second, T cells were costimulated with Fas mAb in the
presence or absence ofa neutralizing IL-2 antiserum . Although
this antiserum completely neutralized the effect ofexogenous
IL-2 on T cell proliferation over a wide range of IL-2 con-
centrations (Fig. 3 A), it had only a minimal effect on Fas
mAb costimulation (Fig. 3 B) .
Fas mAb Directly Costimulates Single T Cells.
￿
To address
the question of whether the T cells were the direct target
ofaction ofFas mAb in T cell activation or whether interac-
tions with accessory cells were required, we used limit dilu-
tion analysis in Terasaki microcultures and analyzed the fre-
quency ofT cells responsive to Fas mAb . This culture system
has been successfully used to analyze the activation require-
ments for single murine T cells (17, 18) . The linear relation-
ship between the number of input cells and the log of the
percent negative wells (Fig. 4) indicates that the precursor
T cell was the limiting component in these cultures. Although
the response varied with different individuals, Fas M38 con-
Figure 2 .
￿
Costimulation with huFas M38 en-
hances CD25 and CD69 expression by CD4+ and
CD8+ T cells. PB T cells were stimulated for 48 h
with either CD3 mAb alone or CD3 mAb plus
huFas M38, and analyzed by two-color flow cyto-
metry using either CD4-PE or CD8-PE together
with CD25-FITC or CD69-FITC . Data are rep-
resentative of three experiments performed .
Table 1 . Fas mAb Costimulates T Cell Cytokine Release
mAb Stimulus IL-2 IFN-,y TNF-a
U/ml pg/ml pg/rnl
Nil <0.1 <5 <5
Fas M38 <0 .1 <5 <5
CD3 0.8 96 110
CD3 + Fas M38 6.7 811 1,318n
a
0
a
U
B
￿
CD3 mAb+Fas M38
25000
20000
15000
10000
5000
0
Figure 3.
￿
Costimulation ofTcell proliferation by Fas mAb is largely
11,2 independent. Peripheral blood T cells were cultured for 72 h with
CD3 mAb and either 11,2 (A) or Fas M38 (B). Cells were cultured in
the presence (") or absence (O) ofa neutralizing 11,2 antiserum at a 1:500
dilution. Data are representative of four experiments performed.
Figure 4.
￿
Effect ofhuFas M38 on the frequency ofproliferating T cell
precursors. Graded numbers of purified T cells were cultured in 15-Al
volumes in wells precoated with either CD3 mAb alone or CD3 mAb
plus Fas M38 mAb in medium containing 10 ng/ml of IL2. After 5 d
the wells were scored microscopically for proliferating T cell clones.
sistently enhanced the frequency ofproliferating T cell clones
by a minimum of threefold and increased the average clone
size by approximately twofold. Thus, the mean frequency
of proliferating T cell clones from four experiments was 16.7%
(23.7 cells/clone) with CD3 plus Fas M38 compared with
1.98% (10.7 cells/clone) with CD3 mAb alone. This result
indicates that the Fas mAb has a direct costimulatory effect
on T cells that does not require the involvement of accessory
cells or other cell types. In addition, the data suggest that
the effects of Fas mAb observed in high density cultures rep-
resent an increase in the frequency of responding T cells as
well as an increase in T cell clonal burst size.
The data presented here demonstrate that Fas is capable
of not only inducing apoptosis in certain transformed cell
lines, but can also be involved in the costimulation offreshly
isolated T cells. These findings are reminiscent of the activity
of TNF since this cytokine not only induces lysis of certain
TNFR-expressing tumor cell lines but can also costimulate
freshly isolated T and B lymphocytes (23, 24). Furthermore,
although TNF induces lysis of certain monocytic cell lines,
it has been reported to inhibit spontaneous apoptosis that
occurs when freshly isolated monocytes are cultured in serum-
free medium (25).
Fas is expressed on a variety of freshly isolated normal cells,
including activated T cells, B cells, monocytes, and neutro-
phils. However, none of these cell types are induced to un-
dergo apoptosis when cultured with Fas-specific mAb (20,
and data not shown). Indeed, at this point only in vitro cul-
tured cell lines have been shown to undergo cytolysis induced
by Fas Ab. In normal cells the primary biological function
of Fas may not necessarily involve apoptosis, but rather in-
volve cellular activation (as demonstrated here with T cells).
Thus, conversion of Fas-mediated signals from activation to
apoptotic may be a component ofthe transformation process
and represent a safety mechanism for the immune system to
eliminate transformed cells from the host by stimulation
through Fas. Alternatively, this signaling conversion may re-
sult from repetitive antigenic stimulation, and as such may
represent a normal mechanism for controlling lymphocyte
expansion/accumulation in vivo. This can be observed in vitro
since long-term antigen-reactive (i.e., chronically stimulated)
CD4+ T cell clones are lysed when cultured with immobi-
lized Fas mAb (data not shown). It would therefore seem
prudent to suggest that the potential role for Fas in cellular
activation warrants a reanalysis ofthe mechanism(s) of gener-
ation of autoimmune disease in mice homozygous for the
lpr gene mutation. The defective expression of Fas in these
mice may give rise to an impairment in lymphocyte activa-
tion or differentiation as well as a failure to regulate self-reactive
T and B cells that in a normal animal would be prevented
from accumulating in the periphery by Fas-mediated pro-
grammed cell death.
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